Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Immunovant Inc., 3 years.
Immunovant Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Immunovant Inc. September 2, 202691.9%
-
Immunovant Inc. August 27, 202589.5%
-
Immunovant Inc. August 12, 202473.7%
-
Immunovant Inc. August 21, 202383.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 7, 2026 | Immunovant Inc. | Grant or award | +13,880 | — | — |
| Dec 1, 2025 | Immunovant Inc. | Open-market sale | −13,091 | $23.14 | $302,926 |
| Dec 1, 2025 | Immunovant Inc. | Open-market sale | −1,909 | $23.96 | $45,740 |
| Apr 1, 2025 | Immunovant Inc. | Grant or award | +16,188 | — | — |
| Dec 2, 2024 | Immunovant Inc. | Open-market sale | −5,425 | $28.54 | $154,830 |
| Apr 2, 2024 | Immunovant Inc. | Grant or award | +11,255 | — | — |
| Apr 12, 2023 | Immunovant Inc. | Grant or award | +12,523 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.